CD14 and type 2 diabetes mellitus: In conclusion, although limited by a lower number of examined subjects, our data suggest an altered basal and glucose-intake-induced response of expression of genes involved in the control of inflammation and lipid metabolism in both CD14+ (mostly monocytes) and CD14- (mostly lymphocytes) PBMC in FDR of T2DM patients when compared with controls.